five

SUPPLEMENTS

收藏
DataCite Commons2022-11-02 更新2024-07-29 收录
下载链接:
https://figshare.com/articles/dataset/SUPPLEMENTS/20576610/2
下载链接
链接失效反馈
官方服务:
资源简介:
This supplement contains <em>Supplementary figure S1 Risk of Bias of Included Studies, </em><em>Supplementary figure S2-S7: Heterogeneity of outcome measures, </em><em>Supplementary figure S8-S20: The Trial Sequential Analysis of the primary outcomes, </em>Table S1. Search Strategy: PubMed, Table S2. Search Strategy: Embase, Table S3. Search Strategy: Cochrane Library, Table S4. Search Strategy: Web of Science, Table S5. Search Strategy: the Chinese Scientific Journal database (VIP), Table S6. Search Strategy: Wanfang database, Table S7. Search Strategy: China National Knowledge Infrastructure (CNKI), Table S8. Search Strategy: SinoMed, <em>Supplementary table S9: Summary of All Included Studies, </em><em>Supplementary table S10: More details about the product information of 7 TCMIs, </em><em>Supplementary table S11: Specific intervention methods of the study, </em><em>Supplementary table S12: Comparisons of the fit of consistency and inconsistency models using deviance information criteria (DIC), </em><em>Supplementary table S14: League table for treatment comparisons in sensitivity analyses by excluding studies that were not within 14 to 30 days of treatment, </em><em>Supplementary table S15: League table for treatment comparisons in sensitivity analyses by excluding studies that were high risk bias, </em><em>Supplementary table S16: The PRISMA checklist of this meta-analysis.</em>

本补充材料包含<em>补充图S1:纳入研究的偏倚风险</em>、<em>补充图S2~S7:结局指标的异质性</em>、<em>补充图S8~S20:主要结局的试验序贯分析</em>;表S1:检索策略:PubMed;表S2:检索策略:Embase;表S3:检索策略:科克伦图书馆(Cochrane Library);表S4:检索策略:Web of Science;表S5:检索策略:中文科技期刊数据库(VIP);表S6:检索策略:万方数据库(Wanfang database);表S7:检索策略:中国知网(China National Knowledge Infrastructure, CNKI);表S8:检索策略:中国生物医学文献数据库(SinoMed);<em>补充表S9:所有纳入研究概况</em>;<em>补充表S10:7种中药注射剂(Traditional Chinese Medicine Injections, TCMIs)产品信息详情</em>;<em>补充表S11:本研究的具体干预方案</em>;<em>补充表S12:基于偏差信息准则(Deviance Information Criterion, DIC)比较一致性与不一致模型拟合效果的结果</em>;<em>补充表S14:剔除治疗周期不在14~30天范围内的研究后,敏感性分析中的治疗比较汇总表</em>;<em>补充表S15:剔除高偏倚风险研究后,敏感性分析中的治疗比较汇总表</em>;<em>补充表S16:本项荟萃分析的PRISMA声明检查表(PRISMA checklist)</em>。
提供机构:
figshare
创建时间:
2022-11-01
5,000+
优质数据集
54 个
任务类型
进入经典数据集
二维码
社区交流群

面向社区/商业的数据集话题

二维码
科研交流群

面向高校/科研机构的开源数据集话题

数据驱动未来

携手共赢发展

商业合作